Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
about
Promising oncolytic agents for metastatic breast cancer treatmentThe Host Cell Receptors for Measles Virus and Their Interaction with the Viral Hemagglutinin (H) ProteinThe tumor-associated marker, PVRL4 (nectin-4), is the epithelial receptor for morbillivirusesConnections matter--how viruses use cell–cell adhesion components.A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells.Development of new therapy for canine mammary cancer with recombinant measles virus.Oncolytic Activity of a Recombinant Measles Virus, Blind to Signaling Lymphocyte Activation Molecule, Against Colorectal Cancer Cells.Oncolytic measles virus strains as novel anticancer agents.Measles virus selectively blind to signaling lymphocyte activity molecule has oncolytic efficacy against nectin-4-expressing pancreatic cancer cells.Evolution of oncolytic viruses: novel strategies for cancer treatment.Antitumor Virotherapy by Attenuated Measles Virus (MV).Oncolytic virotherapy for urological cancers.Naturally Existing Oncolytic Virus M1 Is Nonpathogenic for the Nonhuman Primates After Multiple Rounds of Repeated Intravenous Injections.A bright future for bioluminescent imaging in viral researchAttenuated measles virus controls pediatric acute B-lineage lymphoblastic leukemia in NOD/SCID mice.MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.Construction of an expression system for bioactive IL-18 and generation of recombinant canine distemper virus expressing IL-18.Cytotoxic, Apoptotic and Genotoxic Effects of Lipid-Based and Polymeric Nano Micelles, an In Vitro Evaluation.Computational Analysis of the Interaction Energies between Amino Acid Residues of the Measles Virus Hemagglutinin and Its Receptors.
P2860
Q26830620-240F8E30-C33F-4ABA-9D0D-01626E0ECBDBQ28069519-D85EE1B3-7879-455C-A607-4649BEC9FDB9Q33820699-2A7CFCB4-B4F7-4CD7-9150-A81C0B3D1ADBQ35029152-932426A5-190F-4964-9639-5F3B443A636EQ36413058-21D121A8-85A1-43CA-903C-ABBB297E1FEFQ36664263-94430CAE-D678-48E0-9CC1-19E2C79B3FD9Q36810255-A0EA16BA-FA09-4A07-8512-F38BA6B79A77Q37261017-6F15A989-B0CA-4C43-A038-1471D0E28C03Q37462626-CD29579B-BDC3-488B-97AE-DFE36AD8DBDDQ38159802-3C5555D1-FC17-4928-ACF3-6DD03F659027Q38212137-86D4493B-BC7A-4B45-8DBD-24856AED4F63Q38842126-A7B9D9EB-2CE7-480C-BE08-D3EBBAEB31E2Q38853820-BF83928B-3502-4986-ADE8-00DC2439FF3DQ38959350-19974ADE-3A9F-4777-BC29-0978BE4163D5Q39008033-69F833EF-955D-4869-903B-DAB0EB245441Q40581942-DC0FA37E-5CE4-4499-8877-DBF014874F3AQ42009224-A6142E25-AD67-45C5-B1E8-DACBC1F86B64Q48309189-B2C4EC15-A8B5-4D57-BAB0-49068BA1CF4FQ54214326-D4BE10B1-795D-483D-A4B5-1124066B4FE5
P2860
Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Measles virus selectively blin ...... s for breast cancer treatment.
@en
Measles virus selectively blin ...... s for breast cancer treatment.
@nl
type
label
Measles virus selectively blin ...... s for breast cancer treatment.
@en
Measles virus selectively blin ...... s for breast cancer treatment.
@nl
prefLabel
Measles virus selectively blin ...... s for breast cancer treatment.
@en
Measles virus selectively blin ...... s for breast cancer treatment.
@nl
P2093
P2860
P921
P356
P1433
P1476
Measles virus selectively blin ...... s for breast cancer treatment.
@en
P2093
T Kuraishi
T Sugiyama
P2860
P2888
P304
P356
10.1038/GT.2012.44
P577
2012-06-21T00:00:00Z